<DOC>
	<DOC>NCT03033342</DOC>
	<brief_summary>A phase one study of the safety, tolerability, and pharmacokinetics of a new oxazolidinone antibiotic. Cohorts of healthy adults (female and male) will participate in: single dose escalation study of increasing doses of MRX-4 given by mouth others will participate in multiple dose escalation cohorts of MRX-4 given twice daily by mouth. other cohorts of subjects will participate in the study to evaluate the impact of concomitant food or Omeprazole on safety, tolerability and pharmacokinetics of MRX-4</brief_summary>
	<brief_title>Single Dose Escalation and Multiple Dose Escalation Trial of an Oral Formulation of MRX-4</brief_title>
	<detailed_description />
	<mesh_term>Omeprazole</mesh_term>
	<criteria>Healthy subjects Underlying hepatic, renal, metabolic, hematologic, cardiovascular, or immunologic disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Phase 1</keyword>
</DOC>